FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/08/056143 [Registered on: 04/08/2023] Trial Registered Prospectively
Last Modified On: 03/08/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   To See the Effect of Yavadi Karna Dhoopana, Arka Taila topically and Triphala Guggulu orally in Patients of Karna Srava (Otomycosis) 
Scientific Title of Study   CLINICAL EVALUATION OF YAVADI KARNA DHOOPANA, ARKA TAILA AND TRIPHALA GUGGULU IN KARNASRAVA (OTOMYCOSIS) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Arun Kumar 
Designation  Assistant Professor 
Affiliation  Uttarakhand Ayurved University Harrawala Dehradun 
Address  OPD NO 5 PG Department of Shalakya Tantra Rishikul Campus Haridwar Uttarakhand

Hardwar
UTTARANCHAL
249401
India 
Phone  9634918909  
Fax    
Email  drarun2004@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Arun Kumar 
Designation  Assistant Professor 
Affiliation  Uttarakhand Ayurved University Harrawala Dehradun 
Address  OPD NO 5 PG Department of Shalakya Tantra Rishikul Campus Haridwar Uttarakhand

Hardwar
UTTARANCHAL
249401
India 
Phone  9634918909  
Fax    
Email  drarun2004@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Meena 
Designation  PG Scholar 
Affiliation  Uttarakhand Ayurved University Harrawala Dehradun 
Address  OPD NO 5 PG Department of Shalakya Tantra Rishikul Campus Haridwar Uttarakhand

Hardwar
UTTARANCHAL
249401
India 
Phone  9991328725  
Fax    
Email  meenasheokand734@gmail.com  
 
Source of Monetary or Material Support  
OPD and IPD no 5 Department of Shalakya Tantra Rishikul Campus Uttarakhand Ayurved University Haridwar 
 
Primary Sponsor  
Name  Uttarakhand Ayurved University 
Address  Uttarakhand Ayurved University Harrawala Dehradun 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Meena  Rishikul Campus Haridwar  OPD NO 5 Shalakya Tantra Department Rishikul Campus Haridwar Uttarakhand Ayurved University Harrawala Dehradun
Hardwar
UTTARANCHAL 
9991328725

meenasheokand734@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Uttarakhand Ayurved University, Rishikul Campus Haridwar   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:H608||Other otitis externa. Ayurveda Condition: KARNA-SRAVAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-karNadhUpanam, कर्णधूपनम् (Procedure Reference: Ashtanga Sangraha, Procedure details: there will be three sitttings of 5-5 days with a gap of three days in each sitting (for 5 minutes))
(1) Medicine Name: Triphala Guggulu, Reference: Chakra Dutta, Route: Oral, Dosage Form: Guggulu, Dose: 1(g), Frequency: bd, Duration: 21 Days
(2) Medicine Name: Arka Taila, Reference: Gada Nigraha, Route: Otic, Dosage Form: Taila, Dose: 2(drops), Frequency: tds, Duration: 21 Days
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patients presenting with sign & symptoms of Karnasrava (Otomycosis) like Discharge, Pain, Itching and Feeling of ear blockage- Sravetu puyam 
 
ExclusionCriteria 
Details  Patients of Uncontrolled Diabetes mellitus/ Meningitis/ Tuberculosis/ Pregnant women/ Tympanic membrane perforation and Invasive temporal bone infection 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relief in sign & symptoms of karnasrava like Discharge, Pain, Itching & Feeling of ear blockage  1st 9th 15th 21st 
 
Secondary Outcome  
Outcome  TimePoints 
Reduction of debris present in external auditory canal  1st 9th 15th 21st 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   18/08/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Among 28 ear diseases mentioned  by Acharya Sushruta Karnasrava is one of them . Available treatment protocols for Otomycosis in modern system of medicine relies upon anti-fungal agents, antibiotics and steroids.

Otomycosis is a frustrating entity for both patients and otolaryngologists as it requires long term treatment and medications used for its treatment  has limitations like itchy skin, burning, stinging, swelling, irritation, dizziness, loss of hearing and unusual taste in mouth.

So the present  study will be planned to study the effect of Ayurvedic formulation on Karnasrava.

Case will be selected from OPD/IPD of Rishikul Campus Hospital, U.A.U, Haridwar(UK) INDIA.

A written informed consent will be obtained after counselling of patients participating in the study.

Patients will be treated with Dhoopana therapy, local application and oral drug.

If any ADR is seen, it shall be at once reported at ADR Cell.
 
Close